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An Industry Perspective on the Benefits of and 
Regulation of Genetically Engineered Plants 
NICHOLAS M. FREY 
Pioneer Hi-Bred International, Inc., P.O. Box 85, Johnston, Iowa 50131 
The seed industry has routinely incorporated new technology into its research and development programs. Plant generic engineering is 
the most recent technology to be utilized for seed product development efforts. New sources of herbicide, insect, and disease resistance are 
being incorporated into crop plants using cellular and molecular biology techniques. 
New regulatory guidelines have been developed which require regulatory approval before genetically engineered plants can be reseed in 
the field and ultimately marketed. The impact of these regulations on product development is unclear. Hopefully a dialogue will develop 
among industry, government agencies, and the public such that reasonable and appropriate regulatory procedures evolve. Those 
procedures need to facilitate the development of beneficial plant products while assuring the public that safety and environmental risks 
are acceptable. 
INDEX DESCRIPTORS: Plant genetic engineering, seeds, regulations. 
Future seed product development will draw upon the techniques of 
plant genetic engineering to add useful new traits to our crop plants. 
Plants with improved resistance to herbicides and with resistance to 
lepidopteran insect pests are now in the early stages of product 
development. Crop production will benefit increasingly from biologi-
cal controls of disease and insect pests as a result of recent laboratory 
advances in cellular and molecular biology. 
Industry's objective in investing in research, including genetic 
engineering technologies, is to develop useful new products to sell. 
The prospects for plant genetic engineering have drawn increasing 
attention from the USDA, EPA, and FDA despite the historically 
minimal regulatory oversight in seed product development. Regula-
tory requirements can greatly impact the development of seed 
products that have been improved through genetic engineering. 
Increasing dialogue among industry, government, and the public is 
needed to ensure that reasonable regulatory procedures develop. 
American industry and American agriculture must remain competi-
tive in a world economy. Regulation of seed product development 
must balance the economic and environmental benefits and the risks 
associated with genetically engineered plants. 
The objectives for this paper include describing seed product 
development, providing examples of traits likely to be added to our 
crop plants using genetic engineering technologies, and discussing 
concerns I have about regulatory oversight. Regulatory policies must 
recognize the public's interest for environmental safety while not 
unreasonably constraining the commercialization of molecular genetic 
technology that will benefit agricultural producers and consumers. 
PRODUCT TESTING AS A 
PART OF PRODUCT DEVELOPMENT 
Testing new products to identify those suitable for market intro-
duction and commercial use is an essential component of any well-
managed product development effort. The same is true for products 
developed through molecular biology or genetic engineering as it is 
for products developed through existing or conventional technologies. 
Successful companies are those who effectively utilize available tech-
nology to develop new and useful products for their customers. 
Research-based companies also invest in technology development as well 
as technology application with the assumption that the added cost and 
risk of technology development will be rewarded when new technolo-
gy is effectively delivered to the market. Hewlett-Packard, 3M, and 
Xerox are companies that have successfully delivered technology to 
the market and they have been rewarded for that. The domestic steel 
and auto industries are examples of industries that failed to stay on the 
leading edge of technology development. 
DEVELOPMENT OF HERBICIDE 
RESISTANT CORN HYBRIDS 
I will give you some examples of new technologies that are being 
developed to enhance performance of future seed products. Pioneer is 
currently developing herbicide-resistant corn. The trait was devel-
oped for American Cyanamid by Molecular Genetics Incorporated 
using tissue culture selection. Since genetic engineering was not used, 
our product development has not been restricted by the regulatory 
framework. Nevertheless, genetically engineered herbicide resistance 
will be one of the first commercial developments from biotechnology. 
Critics have stated herbicide-resistant crops are undesirable because 
they will increase usage of herbicides and thereby exacerbate ground 
water contamination problems. Are such criticisms valid? I think not. 
More than 95% of the corn acreage is now treated with herbicide. 
Herbicide-resistant corn will not likely change the percentage of 
treated acres. Furthermore, the herbicide resistance is to a new family 
of herbicides that requires very low use races compared to herbicides 
currently used on corn. Two to four o-dA (140-240 g/ha) of these new 
imidazolinone herbicides will provide weed control similar to that 
achieved by 2 to 6 lbs/ A (2. 2 to 6. 7 kg/ha) of existing corn herbicides. 
The 16-fold decrease in chemical applied to the soil offers a sound 
environmental advantage where ground water contamination issues 
are real concerns. The new herbicides have a performance advantage 
on problem weeds such as shattercane and wild proso millet. Further-
more, the chemicals possess very low mammalian toxicities compared 
to many existing chemicals. I believe that the benefits of this new 
technology clearly outweigh the risks. The commercial acceptance of 
this technology will depend, however, on the economic return 
achieved by rhe farmer ifhe chooses to use this new technology instead 
of his existing technology. 
POTENTIAL FOR INSECT RESISTANCE 
USING BIOTECHNOLOGY 
Biological control of pests whether insect or disease remains an 
elusive, but desirable, commercial business. Plant breeders have 
likely been the most effective developers of commercially viable 
biological control. Crop plants with resistance to one or more diseases 
are common. Insect resistance has been more difficult to accomplish, 
but there are some notable successes. Those include Hessian Fly 
resistance in wheat, greenbug tolerance in sorghum, and pea and blue 
aphid tolerance in alfalfa. Biological control in general has an efficacy 
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ranging from zero to perhaps 70 or 85%, depending on the pest 
pressure and the weather. Biological insecticides such as Dipel or 
Thuricide have such efficacies. These insecticides utilize a bacteria, 
Bacillm thuringiemis. The bacteria produces a protein crystal, i.e., the 
Be toxin, that is toxic ro certain insects when ingested. The products 
are widely used in home gardens to control cabbage loopers and 
tomato hornworms. The biologic insecticides are also used in stored 
grain for Indian meal moth control. The Bacillus insecticide has very 
short residual activity when exposed to ultraviolet light, and thus 
repeated applications at perhaps 3-day intervals are required for 
sustained insect control. The produces have not been very successful 
for European corn borer control in corn because of this short efficacy 
period and the expense of repeated applications. Molecular biologists 
have cloned the gene for Br toxin from Bacillus thuringiemis and have 
inserted the bacterial toxin gene into plants. The Be protein is 
produced in plant leaves at levels sufficient to make the plants insect 
resistant. Be toxin is not toxic to mammals, including humans. 
Insects have an alkaline gut that breaks the Be protein into a 
component toxic to the insect. The Be protein is simply digested 
without harmful effect in mammals which have an acid gut. Genetic 
engineering may make biological control commercially viable where 
it has had limited success ro date. 
Making biological control competitive with chemical control 
seems a worthy goal to pursue. The American consumer has demand-
ed consistent insect control in our fruit and vegetable products. Only 
chemical insecticides have provided the necessary level of insect 
control. If genetic engineering improves plant insect resistance, for 
example by producing Br toxin that is stable when exposed to 
sunlight, biological control may displace some chemical controls. 
That could enhance profitability to producers and offer desirable 
environmental benefits as well. 
NECESSI1Y OF GENETIC ENGINEERING 
IN REMAINING COMPETITIVE 
Pioneer Hi-Bred International is a research-based company, and we 
plan to use available technology to develop useful, new seed products 
for our customers. That includes using genetic engineering technolo-
gy co introduce new, desirable genes or traits into plants. We must use 
genetic engineering technology as aggressively as we have used the 
computer or other technologies to enhance ou~ product development 
if we are to remain competitive in the genetIC supply busmess. To 
ignore technology due to regulatory uncertainty, due to a poorly 
informed public's concern over safety of the technology, or due to our 
unwillingness to risk the research investment is to renege on our 
commitment to deliver superior seed products to our customers. We 
must compete in the international arena of seed product development 
if we are to survive as a company and if we are to deliver seed products 
to our customers that will maximize their profitabililty. It is from this 
perspective that Pioneer views testing and marketing geneti~ally 
engineered plants. This perspective is likely _shared by _most agr~cul­
tural companies developing genetically engmeered mICroorgamsms 
and animal products. I think it should be a perspewve shared by 
fu.rmers who realize how critical being the low-cost producer of 
agricultural commodities is to their survival in t~ay's worl~ ec~nomy. 
It is a perspective our steel and auto producers failed to mam~am,_ and 
they are struggling to regain their competitiveness and profoab1ltty. 
CONCERNS ABOUT REGULATORY COSTS 
FOR PRODUCT DEVELOPMENT USING 
GENETIC ENGINEERING 
That pragmatic view of the utility of genetic engineering might 
suggest that Pioneer or perhaps industry in general should pursue chis 
new technology without regard for public safery or the environment. 
Clearly that cannot and will not be done. But what risk does genetic 
engineering technology pose? Newspaper accounts, ofren reporting 
scientists' claims or testimony before congressional committees, 
convey the message that genetic engineering technology is both 
powerful and useful. Others, including critics of the technology, point 
out risks they perceive from genetic engineering. The regulatory 
framework published in the June 26, 1986, Federal Register demon-
strates the concern of the regulatory agencies who are charged with 
protecting the public health and welfare. I am not here to tell you that 
there are no risks associated with genetic engineering technology. 
There are risks associated with any new technology. There are also 
benefits. Pioneer is anxious to exploit the benefits of genetic engineer-
ing technology. We want to do so prudently such that benefits clearly 
ourweigh risks. I feel the industry, the general public, and the 
government must work together to consider the risks and the benefits 
of applying genetic engineering to improve the efficiency of our 
agriculture, to diversify our agricultural production, to improve 
human health, co improve animal health, and to improve biological 
processing. Regulatory oversight is needed as we develop the technol-
ogy. Yet chat oversight must be consistent with the risks that are likely 
to be encountered, and quite frankly, consistent with the profit 
potential of a given product. If expenses to gain regulatory approval 
exceed the profit potential of the finished product, there will be no 
new product developed by the private sector. 
I am concerned that the regulatory requirements currently being 
implemented may prove co be overly restrictive. How the various 
agencies will interpret and implement the regulations are not fully 
known. Pioneer and other companies have provided input to govern-
mental agencies as the rules were developed. The industry has 
recognized the need for reasonable regulations. We have also recom-
mended chat provisions be made to relax the regulatory requirements 
as experience suggests such relaxation is warranted. The_ C1;1frent 
regulations may be sufficiently burdensome to severely limit the 
development of the technology for the good of American agricult'.-1re, 
the good of American business, and yes, the good of t~e Amencan 
public. We get mixed signals from the regulatory agei:ines, ~d that 
will likely continue until the coordinated framew?rk _is fully _imple-
mented. This regulatory uncertainty poses some s1g01ficant nsks for 
industry. An example may help make the point chat products can be 
regulated out of the market. Let's assume chat genetic engii:ieering of 
soybeans and wheat is possible, and we have a gene that will control 
cyst nematode of soybean and one that will control Russian _wh~t 
aphid in wheat. Let's also assume each variety with the new trait will 
be treated as a new pesticide under the regulatory framework. Expense 
to meet USDA/EPA requirements for field testing will be several 
thousand dollars unless long-term animal toxicology studies are 
required. That will be an agency decision. The costs would then 
escalate to $1 to 2 million. Alternatively, if FDA feels a gene chat 
enhances lysine content of cereal proteins must be considere~ ~food 
additive FDA food additive approvals can cost over $10 million. If regulato~ costs approach $1 million or more ~or a single seed variety, 
it is unlikely that a seedsman can afford to deliver that l?r~uct to the 
market. Pioneer has had few if any soybean or wheat var1et1es generate 
$1-2 million in profit before being replaced by a new variety. In fact, 
total net contribution over the past 5 years for Pioneer's entire soybean 
product line has been $7.5 million, and Pioi:ieer's wheat p~uct _line 
has lost $4.4 million for the same 5-year penod. Those conmbut1ons 
are before indirect costs and tax payments are removed. How much 
regulatory expense can these self-pollinated crops ~ord? Do w_e want 
more effective biological control of insects and disease pest m self-
pollinated crops? 
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BALANCING REGULATORY COSTS 
AND PRODUCT BENEFITS 
How can we keep regulatory costs low while providing for public 
safery? We must find an answer to that question if com~ies are to 
deliver genetic engineering technology co the market ~d 1f we _are ~o 
rely more heavily on biological control in crop produc~10n. This will 
require industry, government, and the general public to work to-
gether to assess the risks and the benefits of the technology, and to 
implement regulations that support the development of the technolo-
gy while not threatening public welfare. le is urgent chat we begin 
developing the experience we need to identify the real versus perceived 
risks of the technology. It is also urgent for us to examine our 
experiences in field testing conventional produces as chose experiences 
may predict risks associated with products developed using these 
newer technologies. Small-scale field tests of genetically engineered 
planes in an isolated location where the planes are not all?wed to si:c 
seed will not provide much valuable experience, yet that 1s all chat ~s 
being allowed today. Furthermore, it is not clear how to gee from this 
initial field test to a commercial product which can be sold to a farmer. 
Clearly more work has to be done. The work can only be done if we 
avoid being adversaries and instead decide we must answer the 
questions together. We need to lay all the problems on the cable and 
decide which are real and which are perceived. We need to share 
relevant data and experiences that are pertinent to risk assessment. 
Relevant data do exist. Then we can work co solve the real problems, 
ensuring chat benefits to society are weighed along with risks. 
Mistakes may be made, but under reasonable guidelines potential 
harm will be minimized and the information gained more valuable 
than if no experience were gained. The mistake I fear most is that we 
will be so cautious that beneficial produces are denied society. Of 
course we cannot put a price on what could have been unless a 
competitor, either domestic or foreign, succeeds at our expense. 
